Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis. The company was formerly known as Hubei Hongcheng General Machinery Co., Ltd and changed its name to Hubei Jumpcan Pharmaceutical Co., Ltd. in March 2015. Hubei Jumpcan Pharmaceutical Co., Ltd. is based in Taixing, China.
Hubei Jumpcan Pharmaceutical Dividend Announcement
• Hubei Jumpcan Pharmaceutical announced a annually dividend of ¥1.30 per ordinary share which will be made payable on 2024-06-17. Ex dividend date: 2024-06-17
• Hubei Jumpcan Pharmaceutical annual dividend for 2024 was ¥1.30
• Hubei Jumpcan Pharmaceutical annual dividend for 2023 was ¥0.88
• Hubei Jumpcan Pharmaceutical's trailing twelve-month (TTM) dividend yield is 4.51%
• Hubei Jumpcan Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 72.71%
• Hubei Jumpcan Pharmaceutical's dividend growth over the last five years (2018-2023) was -2.52% year
Hubei Jumpcan Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-06-17 | ¥1.30 | annually | 2024-06-17 |
2023-07-03 | ¥0.88 | annually | 2023-07-03 |
2022-05-26 | ¥0.68 | annually | 2022-05-26 |
2021-05-26 | ¥0.45 | annually | 2021-05-26 |
2020-04-24 | ¥1.23 | annually | 2020-04-24 |
2019-06-03 | ¥1.23 | annually | 2019-06-03 |
2018-06-01 | ¥1.00 | annually | 2018-06-01 |
2017-04-28 | ¥0.73 | annually | 2017-04-28 |
2016-04-20 | ¥0.70 | annually | |
2015-04-07 | ¥0.40 | annually | |
2012-05-16 | ¥0.01 | annually | |
2011-07-12 | ¥0.01 | annually |
Hubei Jumpcan Pharmaceutical Dividend per year
Hubei Jumpcan Pharmaceutical Dividend growth
Hubei Jumpcan Pharmaceutical Dividend Yield
Hubei Jumpcan Pharmaceutical current trailing twelve-month (TTM) dividend yield is 4.51%. Interested in purchasing Hubei Jumpcan Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Hubei Jumpcan Pharmaceutical Financial Ratios
Hubei Jumpcan Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Hubei Jumpcan Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Hubei Jumpcan Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Hubei Jumpcan Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Hubei Jumpcan Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Hubei Jumpcan Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Hubei Jumpcan Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Hubei Jumpcan Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Hubei Jumpcan Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Hubei Jumpcan Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Hubei Jumpcan Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Hubei Jumpcan Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.